|
PURA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78812520346128E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.70785607878088E-12 |
| Normal-vs-Stage2 |
2.43450004600021E-09 |
| Normal-vs-Stage3 |
1.86430000326254E-08 |
| Normal-vs-Stage4 |
5.797700E-03 |
| Stage1-vs-Stage2 |
9.458000E-01 |
| Stage1-vs-Stage3 |
4.517600E-01 |
| Stage1-vs-Stage4 |
5.719000E-01 |
| Stage2-vs-Stage3 |
4.671000E-01 |
| Stage2-vs-Stage4 |
5.568000E-01 |
| Stage3-vs-Stage4 |
9.281000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68642877440561E-12 |
| Normal-vs-AfricanAmerican |
5.27633492453106E-12 |
| Normal-vs-Asian |
1.64789999999027E-05 |
| Caucasian-vs-AfricanAmerican |
9.077400E-01 |
| Caucasian-vs-Asian |
8.581000E-01 |
| AfricanAmerican-vs-Asian |
8.047000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.78449996393704E-09 |
| Male-vs-Female |
2.038100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.15329976072098E-11 |
| Normal-vs-Extreme_Weight |
3.40838468559923E-14 |
| Normal-vs-Obese |
1.27620003453899E-09 |
| Normal-vs-Extreme_Obese |
3.96439999716947E-08 |
| Normal_Weight-vs-Extreme_Weight |
7.393800E-01 |
| Normal_Weight-vs-Obese |
1.161580E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.902800E-01 |
| Extreme_Weight-vs-Obese |
1.474790E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.554000E-01 |
| Obese-vs-Extreme_Obese |
3.367400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.87640003534995E-09 |
| Normal-vs-Age(41-60Yrs) |
1.05999986566019E-10 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.39739997351285E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.224200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.159600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.410800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.083990E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.566300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.433800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.88178419700125E-15 |
| Normal-VS-Type2 PRCC |
5.37014877011188E-13 |
| Normal-VS-KIRP CIMP |
3.67469999984493E-07 |
| Normal-VS-Unclassified PRCC |
6.22789999999984E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.458800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.166800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.655600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.435000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.033800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.176400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.40443212615082E-12 |
| Normal-vs-N1 |
1.9251000005216E-07 |
| Normal-vs-N2 |
3.86880000002865E-06 |
| N0-vs-N1 |
1.107960E-01 |
| N0-vs-N2 |
4.513200E-01 |
| N1-vs-N2 |
1.199610E-01 |
|
|
